OnKure Therapeutics, Inc. (OKUR) Free cash flow 2020–2025
OnKure Therapeutics, Inc. (OKUR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$51.9MFY2025 · since FY2020: -$18.6M → -$51.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.9M | -1.4% |
| FY2024 | -$51.2M | -47.1% |
| FY2023 | -$34.8M | +27.1% |
| FY2022 | -$47.7M | -25.0% |
| FY2021 | -$38.2M | -105.7% |
| FY2020 | -$18.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice